Calypte Announces Second Quarter Financial Results; Company to Accelerate U.S. Studies of Rapid HIV Test.
Linked as:
Extract
Calypte Announces Second Quarter Financial Results; Company to Accelerate U.S. Studies of Rapid HIV Test.
Business Editors & Health/Medical Writers
ALAMEDA, Calif.--(BW HealthWire)--July 24, 2002 Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA-approved serum HIV-1 antibody Western Blot supplemental test, today announced financial results for the second quarter and six months ended June 30, 2002. The net loss attributable to ...See the full content of this document
Sponsored links
